Woodcock: Naming Drugs In Shortage From COVID-19 Could Cause Alarm

By Beth Wang / March 11, 2020 at 7:11 PM
FDA drug center chief Janet Woodcock argued against revealing the names of drugs that are in shortage because of the COVID-19 pandemic, saying not only is the agency not allowed to share that information but that revealing it would confuse those who aren’t experts in the drug space and could create panic. The agency in February reported one human drug is in shortage because of coronavirus . That drug was added to FDA’s database, which lists nearly 150 current and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.